COVID-19 grave y embarazo: a propósito de dos casos alrededor de la viabilidad fetal / Severe COVID-19 and pregnancy: on purpose of 2 cases around fetal viability

Resumen El presente trabajo describe la evolución de dos casos clínicos graves de COVID-19 en pacientes embarazadas con 27 y 24 semanas de amenorrea. A partir de estos casos se resume la evidencia disponible en la literatura en relación con el curso grave de la enfermedad durante el embarazo y se sugieren guías para considerar en la reflexión multidisciplinaria que permite manejar y resolver casos similares.

Abstract The present article describes the evolution of two clinical cases of severe COVID-19 in pregnant patients with 27 and 24 weeks of gestational weeks. The available up-to-date evidence about severe course of the disease during pregnancy is resumed. Management guides are suggested for the multidisciplinary approach of similar cases.

En mujeres embarazadas con rotura prematura de membranas y edad gestacional entre 34 y 37 semanas: ¿Es la interrupción del embarazo (manejo activo) mejor que el manejo expectante para reducir la sepsis neonatal? / In pregnant women with premature rupture of membranes and gestational age between 34 and 37 weeks: Is termination of pregnancy (active management) better than expectant management to reduce neonatal sepsis?

INTRODUCCIÓN: La rotura prematura de membranas (RPM) ocurre en un 8 a 10% de las embarazadas, y de ellas, un 20% corresponde a embarazos de pretérmino. El mayor riesgo para el feto luego de una RPM pretérmino son las complicaciones propias de la prematurez. Por debajo de las 34 semanas se favorece el manejo expectante, y el uso de antibióticos y corticoides. Entre las 34 y 37 semanas, sin embargo, las prácticas varían, no habiendo un consenso claro sobre la conducta óptima. OBJETIVO: El objetivo de esta revisión es explorar la evidencia actualmente disponible respecto de la conducta activa versus la expectante en embarazos con RPM entre las 34 y 37 semanas (36 semanas más 6 días). METODOLOGÍA: Se realizó una búsqueda de literatura médica en distintas bases de datos, dentro de las cuales se incluye "PubMed" y "Cochrane", usando los siguientes términos: "Fetal Membranes, Premature Rupture", "Premature Birth", "34 and 37 weeks" y "Clinical Trial". Se limitó la búsqueda a artículos que fueran ensayos clínicos aleatorizados. De un total de 31 trabajos, se seleccionaron 3, a los cuales se les aplicó la pauta de análisis crítico para evaluación de estudios de terapia. RESULTADOS: Se incluyeron 3 estudios que respondían a la pregunta planteada. En el primer estudio se concluyó que en pacientes en que hay interrupción inmediata la incidencia de sepsis neonatal es baja y no es posible demostrar que esta conducta mejore los resultados en comparación con el manejo expectante (2.6% vs. 4.1%). El manejo activo en este estudio se asoció a mayor incidencia de hiperbilirrubinemia, hipoglicemia, y mayor estadía hospitalaria neonatal. En el segundo artículo se planteó que la incidencia de sepsis neonatal sigue siendo baja, lo cual no disminuyó con la inducción del trabajo de parto. Esta tampoco disminuyó el riesgo de otros resultados neonatales o maternos. Finalmente, el tercer estudio concluyó que la interrupción inmediata aumenta las complicaciones neonatales sin disminución de la sepsis neonatal, pero a expensas de mayor frecuencia de fiebre materna y de hemorragia intraparto. CONCLUSIONES: El manejo expectante no es inferior al manejo activo en el contexto de RPM entre las semanas 34 a 37 de edad gestacional.

INTRODUCTION: Premature rupture of membranes (PROM) occur in eight to ten percent of pregnancies, and 20 percent of them occur in preterm pregnancies. Biggest fetal risks after preterm PROM are complications due to prematurity. Before 34 weeks of gestation it is preferred an expectant management, and the use of antibiotics and steroids. Between 34 and 37 weeks, however, practices are variable without a clear consensus about the best management. OBJECTIVE: The objective of this review is to explore the available evidence about active versus expectant management in pregnancies with PROM between 34 and 37 weeks (36 weeks plus 6 days). METHODS: Different databases were searched for medical literature, including 'PubMed' and 'Cochrane', using the following terms: 'Fetal Membranes, Premature Rupture', 'Premature Birth', '34 and 37 weeks' and 'Clinical Trial'. The search was limited to clinical randomized trials. From a total of 31 studies, three were selected, in which critical analysis guidelines for evaluation of therapy studies were applied. RESULTS: Three clinical trials which answered our question were included in this review. The first study concluded that in patients whose pregnancies were interrupted immediately, the incidence of neonatal sepsis was low but is was not able to demonstrate that this action improved outcomes compared to expectant management (2.6% vs 4.1%). Active management in this study was associated to greater incidences of hyperbilirubinemia, hypoglycemia and longer neonatal hospital stay. In the second article the incidence of neonatal sepsis was low and didn't decrease with induction of labor. It also didn't reduce the risk of other maternal nor neonatal outcomes. Finally, the third study concluded that induction of labor increased neonatal complications without reducing neonatal sepsis, but at the expense of increased frequency of intrapartum hemorrhage and maternal fever. CONCLUSION: After analyzing the selected articles, it is possible to conclude that there is enough evidence to say that expectant management is not inferior to active management in relation to PROM between 34 and 37 weeks of gestational age.

Hantavirus y embarazo: aspectos hemodinámicos y respiratorios / Hanta virus and pregnancy: hemodynamic and respiratory aspects

The disease by Hanta virus has a recent diagnose in our country. 218 cases have been reported to date and given its high mortality of 44 percent, a great epidemiological campaign has been implemented, for its isolation and control. The most severe form of this disease, Hanta virus, is the cardio pulmonary syndrome which present characterics that difference it from other similar disorders. The more frequent hemodynamics patrons to find are low cardiac indexes (CI) with pulmonary vascular resistences and elevated (RVS) systemic. On the other hand, the respiratory disorders correspond to a pulmonary edema non cardiogenic, similar to acute respiratory distress syndrome (SDRA). There are few reports of Hanta in pregnant patients described in literature and case present a high rate of fetal and maternal mortality and there is not a clear description of the hemodynamic compromise, or certitude if there is vertical transmission of the virus from the infected mother to the fetus. We described the clinical case of a 12 weeks pregnant patient with cardio pulmonary syndrome due to Hanta virus (SCPH) which shws a different hemodynamics patron than which has been published and who survives both she as well as her child and do not present virus transmission to the fetus